Rezultati pretraživanja
  1. prije 1 sat
  2. Prospective Molecular Profiling of Circulating Tumor Cells from Patients with Melanoma Receiving Combinatorial Immunotherapy

  3. prije 1 sat

    : researchers developed a "molecular switch" to improve the safety of chimeric antigen receptor T-cell therapies. The technique may help protect the patient from life-threatening side effects or prevent T-cell exhaustion -

  4. single-cell genomics: engine for target identification and drug development

  5. prije 3 sata

    👇an amazing opportunity to move the needle and make an impact 👇

  6. prije 5 sati

    sciencemagazine: Pairing the EGFR inhibition and PD-1 checkpoint blockade immunotherapy has remained controversial. Now, a NagoyaUniv study in SciImmunology offers new insights for when the drug duo can show promise as a lung : …

  7. prije 6 sati

    Doctors Really Wish You'd Stop Ignoring These Sneaky Health Symptoms

  8. prije 7 sati

    RESEARCH: New type of may better treat . (via UCLA UCLA Broad Stem Cell)

  9. After seeing the success of in stage IV MCC patients, researchers are exploring if the therapy could benefit other MCC patients. What is this new treatment, and why is it such a big step forward?

  10. Advances in presurgical are an important next step for enhancing the response of early-stage tumors to immune checkpoint blockade. Read more in this : ($)

  11. 24th Edition of International Conference on Immunology & Infectious Diseases-London,UK June 15-16, 2020. Theme: Exploring the human immune system & Infectious Diseases. Book your Slots............

  12. For sesson on " basically boosts the patient's own immune system to fight against cancer cells better," says Seungpyo Hong, a professor in the UW-Madison School of Pharmacy.

  13. 2. velj

    Interesting graph , measles is far more dangerous lucky most people have had

  14. 1. velj

    Wonderful gift from a patient successfully treated with

  15. 1. velj

    I'm honestly shocked that patients might still be treated with isolated limb infusion with cytotoxic today, when and targeted therapy are so effective. This isn't new; it's over 20 years old.

  16. How does the immune system work against cancer? Our video shows 3 types of , including drugs known as immune checkpoint inhibitors:

  17. Researchers are exploring ways to expand the types of immune cells that can be used for , as our infographic explains:

  18. From the January issue - a news article discussing the pipeline of immune agonist antibodies as the first one enters phase III trials And for more on agonist antibodies in cancer , here's a recent review

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.